News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,917 Results
Type
Article (39146)
Company Profile (283)
Press Release (648488)
Section
Business (203900)
Career Advice (1996)
Deals (35371)
Drug Delivery (89)
Drug Development (80849)
Employer Resources (168)
FDA (16098)
Job Trends (14808)
News (344641)
Policy (32450)
Tag
Academia (2530)
Alliances (49183)
Alzheimer's disease (1259)
Approvals (16056)
Artificial intelligence (144)
Bankruptcy (352)
Best Places to Work (11581)
Biotechnology (200)
Breast cancer (188)
Cancer (1368)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (281)
Clinical research (64694)
Collaboration (482)
Compensation (262)
COVID-19 (2541)
C-suite (108)
Data (1391)
Diabetes (174)
Diagnostics (6170)
Earnings (84893)
Employer resources (146)
Events (110007)
Executive appointments (394)
FDA (16777)
Funding (426)
Gene therapy (195)
GLP-1 (598)
Government (4333)
Healthcare (18693)
Infectious disease (2633)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16339)
Job creations (3625)
Job search strategy (1418)
Layoffs (418)
Legal (7861)
Lung cancer (197)
Lymphoma (98)
Manufacturing (206)
Medical device (13212)
Medtech (13217)
Mergers & acquisitions (19192)
Metabolic disorders (456)
Neuroscience (1579)
NextGen Class of 2024 (6500)
Non-profit (4467)
Northern California (1696)
Obesity (259)
Opinion (183)
Patents (117)
People (56457)
Phase I (20120)
Phase II (28493)
Phase III (21238)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (261)
Real estate (5890)
Regulatory (21675)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1460)
Startups (3562)
United States (15157)
Vaccines (563)
Weight loss (182)
Date
Today (24)
Last 7 days (573)
Last 30 days (2274)
Last 365 days (35184)
2024 (35025)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (195)
Asia (37269)
Australia (6087)
California (3812)
Canada (1449)
China (306)
Colorado (171)
Connecticut (176)
Europe (79825)
Florida (535)
Georgia (135)
Illinois (384)
Indiana (225)
Maryland (628)
Massachusetts (2963)
Michigan (172)
Minnesota (290)
New Jersey (1101)
New York (1082)
North Carolina (742)
Northern California (1696)
Ohio (146)
Pennsylvania (923)
South America (1092)
Southern California (1460)
Texas (548)
Utah (108)
Washington State (399)
687,917 Results for "syndevrx inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Cambridge-Based Biotech SynDevRx Announces Scientific Publication Describing Optimized Drug Conjugate Targeting Tumors Sensitive to Obesity/Metabolic Hormones
SynDevRx, Inc., a pioneering clinical-stage biotechnology company based in Cambridge, Massachusetts, has achieved a significant milestone.
March 28, 2024
·
5 min read
Business
SynDevRx Announces Research Collaboration with Queensland University of Technology (QUT) to Study the Effects of SDX-7320 In Advanced Prostate Cancer Models
SynDevRx, Inc. today announced a research collaboration with Australia’s Queensland University of Technology.
December 7, 2021
·
6 min read
Drug Development
New Phase 1b/2 Clinical Research Study with SynDevRx Drug Evexomostat (SDX-7320) Announced for Triple-Negative Breast Cancer Patients with Baseline Insulin Resistance
SynDevRx, Inc. today announced the opening of a first-of-its-kind Phase 1b/2 study for patients with triple-negative breast cancer and baseline insulin resistance, testing the novel study drug evexomostat (SDX-7320).
June 1, 2022
·
6 min read
Genetown
SynDevRx To Present Pre-Clinical Combination Data of Evexomostat (SDX-7320) with Capivasertib (AZD-5363) During The 2021 San Antonio Breast Cancer Symposium
SynDevRx, Inc. today announced they will be presenting pre-clinical mechanistic/molecular data with evexomostat (SDX-7320) using the Her2+ xenograft model (BT474) in combination with capivasertib/AZD-5363 during the 2021 San Antonio Breast Cancer Symposium.
December 8, 2021
·
3 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Press Releases
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
December 20, 2024
·
2 min read
Press Releases
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
December 12, 2024
·
19 min read
Press Releases
BRIJ Medical, Inc. Awarded Breakthrough Technology Agreement in the Non-Invasive Skin Closure Category with Premier, Inc.
December 17, 2024
·
2 min read
Press Releases
CorMedix Inc. Added to Nasdaq Biotechnology Index
December 20, 2024
·
1 min read
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
1 of 68,792
Next